## Abstract Epidemiological studies indicate that menopausal estrogenβprogestin therapy (EPT) use is associated with an increase in breast cancer risk. Further data are needed on whether this association varies by specific prognostic factors and ethnicity. We conducted a cohort study among 55,371 A
Postmenopausal hormone therapy and cancer risk
β Scribed by P. Kenemans; R.A. Verstraeten; R.H.M. Verheijen
- Book ID
- 116537560
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 96 KB
- Volume
- 1279
- Category
- Article
- ISSN
- 0531-5131
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Hormone therapy (HT) and body mass index (BMI) have been associated with postmenopausal breast cancer. Because estrogen metabolism may affect breast cancer risk and can be altered by weight and HT, it might play a role in the HTβBMIβbreast cancer associations. We undertook a nested case
## Abstract We investigated whether variants in sex steroid hormone metabolism genes modify the effect of hormone therapy (HT) on endometrial cancer risk in postmenopausal nonβHispanic white women. A nested caseβcontrol study was conducted within the California Teachers Study (CTS). We genotyped ht